Last reviewed 2026-05-13 · How we verify

topical BPM31510 3.0% Cream

Shasa Hu · Phase 1 active Small molecule Quality 0/100

topical BPM31510 3.0% Cream is a Small molecule drug developed by Shasa Hu. It is currently in Phase 1 development.

At a glance

Generic name	topical BPM31510 3.0% Cream
Sponsor	Shasa Hu
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

topical BPM31510 3.0% Cream CI brief — competitive landscape report
topical BPM31510 3.0% Cream updates RSS · CI watch RSS
Shasa Hu portfolio CI

Frequently asked questions about topical BPM31510 3.0% Cream

What is topical BPM31510 3.0% Cream?

topical BPM31510 3.0% Cream is a Small molecule drug developed by Shasa Hu.

Who makes topical BPM31510 3.0% Cream?

topical BPM31510 3.0% Cream is developed by Shasa Hu (see full Shasa Hu pipeline at /company/shasa-hu).

What development phase is topical BPM31510 3.0% Cream in?

topical BPM31510 3.0% Cream is in Phase 1.

Manufacturer: Shasa Hu — full pipeline
Compare: topical BPM31510 3.0% Cream vs similar drugs
Pricing: topical BPM31510 3.0% Cream cost, discount & access